Kailera Therapeutics · 1 day ago
Senior Scientist, Analytical Development and Quality Control
Kailera is committed to developing therapies that empower individuals to enhance their health, fostering a collaborative and inclusive workplace. The Senior Scientist in Analytical Development and Quality Control will oversee analytical activities conducted by external partners, ensuring compliance with regulatory standards while supporting quality control and product integrity.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Participate in the assessment and selection of Contract Development and Manufacturing Organizations (CDMOs)
Oversee analytical activities conducted by these CDMOs to ensure external partners fulfill technical needs and quality standards
Perform detailed review and provide data integrity oversight of data generated at CDMOs
Ensure appropriate methods are developed and implemented for drug substance and drug product based on identified critical quality attributes
Provide oversight of phase-appropriate method validation activities in alignment with current regulatory requirements
Oversee stability programs to support product retest, shelf-life, and expiration dating
Contribute to the preparation of data summaries and reports, and data review of regulatory submissions (INDs, NDAs, IMPDs)
Ensure analytical methods and data meet regulatory requirements, generate data to justify specification limits, and assess trends in stability data
Ensure all analytical activities comply with GMP, ICH guidelines, and other relevant regulations
Participate in internal and external investigations of quality events (e.g., deviations, CAPAs, OOS, etc.)
Work closely with Manufacturing and Quality Assurance teams to generate cGMP compliant data during product development and manufacturing
Provide technical guidance and support to internal teams and external partners
Oversee the preparation and review of technical documents, including protocols, reports, and SOPs
Ensure data integrity and traceability in all analytical documentation
Qualification
Required
PhD with a minimum of 6 years, MS with a minimum of 10 years, or BS with a minimum of 12 years of experience in analytical development and quality control within the pharmaceutical or biotech industry
Proven experience with peptides and small molecules in both injectable and solid oral dosage forms
Experience managing outsourced activities with CDMOs
Strong expertise in analytical techniques such as HPLC, UPLC, MS, GC, and spectroscopic methods
Knowledge of regulatory requirements (FDA, EMA) and ICH guidelines related to analytical development
Proven effective communication and interpersonal skills
Ability to work effectively in a fast-paced, collaborative environment
Preferred
Experience with combination drug/device presentations is preferred
Experience with establishing peptide drug substance analytical control strategy for various peptide synthesis modalities (linear SPPS, hybrid approaches, LPPS, and/or recombinant) is preferred
Benefits
Comprehensive health coverage
Flexible time off
Paid holidays
Year-end shutdown
Monthly wellness stipend
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants
Company
Kailera Therapeutics
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Funding
Current Stage
Growth StageTotal Funding
$1BKey Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M
Recent News
2026-01-05
2025-12-24
2025-12-17
Company data provided by crunchbase